comparemela.com
Home
Live Updates
Can 3110 - Breaking News
Pages:
Latest Breaking News On - Can 3110 - Page 1 : comparemela.com
FDA Grants Fast Track Designation to CAN-3110 for Recurrent High-Grade Glioma
CAN-3110, an HSV-1 oncolytic viral immunotherapy candidate, has received FDA fast track designation for adult patients with recurrent high-grade glioma.
Massachusetts
United-states
Boston
Antonio-chiocca
Harvard-medical-school
Department-of-neurosurgery-at-brigham
Peter-tak
Candel-therapeutics
Can-3110
Adult-patients-with-recurrent-high-grade-glioma
Paul-peter-tak
D
vimarsana © 2020. All Rights Reserved.